In a recent interview with Diagnostic Imaging, Eliad Josephson discussed key attributes of the HLTH USA conference, AI trends and an ongoing shift of emphasis on the development of predictive technologies with diagnostics at center stage.
Commentary|Slideshows|June 26, 2026
SNMMI 2026: Highlighted Interviews
Author(s)Diagnostic Imaging Staff
Catch up on recent interviews with Michael Hofman, MBBS, FRACP, Heather Jacene, MD, Phillip Kuo, MD, and more discussing new research and advances presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 conference.
Advertisement
Whether it was new comparative research preliminary research examining the urinary radioactivity of leading PSMA PET radiotracers, an interview with new SNMMI president Heather Jacene, MD or pertinent insights on an emerging total body PET/CT system with a long axial field of view, we learned quite a bit during our time at the Society of Nuclear Imaging and Molecular Imaging (SNMMI) 2026 conference in Los Angeles. Review the slideshow below to check out some of our interviews with key opinion leaders on new research and advances presented at the conference.
Advertisement
Related to this article
In a recent interview, Phillip Koo, MD, discussed emerging trends with AI, theranostics and empowered patients, and how these developments may lead to challenges and potential opportunities for radiologists and nuclear medicine physicians.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.
In a recent interview, Amir Iravani, MD, FRACP, discussed the radiotherapeutic agent 177Lu-edotreotide and new dosimetry data from the COMPETE trial that was recently presented at the ASTRO conference.
In the first of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, reviewed key findings from a study examining CT radiation dosing over the past decade and shared insights from their experience for ensuring optimal radiation dosing for CT scans.
In a new webinar program, Raj Chopra, MD and Peter Reilly share their insights on the importance of cybersecurity, keys to effective downtime communication, the ripple effects and costs of security breaches, challenges with AI and practical safeguards.
The AI-powered NeuroDR software reportedly removes bone, soft tissue and veins from CTA scans and provides subsequent 3D MIP views and curved planar reformatted views of carotid and vertebral arteries.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears CTA-Based AI Software for Enhanced Visualization of Head and Neck Arteries
2
Webinar: Current Perspectives and Recommendations on Ensuring Cybersecurity
3
Advances in AI — October 2026
4
The Reading Room Podcast: Emerging Research and Current Perspectives on CT Radiation Dosing, Part 1
5